Scorpius Holdings Files 8-K
Ticker: SCPX · Form: 8-K · Filed: Mar 7, 2024 · CIK: 1476963
| Field | Detail |
|---|---|
| Company | Scorpius Holdings, Inc. (SCPX) |
| Form Type | 8-K |
| Filed Date | Mar 7, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0002 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-update, financial-condition
Related Tickers: SCPX
TL;DR
Scorpius Holdings (SCPX) filed an 8-K, expect operational/financial updates soon.
AI Summary
On March 7, 2024, Scorpius Holdings, Inc. (formerly NightHawk Biosciences, Inc. and HEAT BIOLOGICS, INC.) filed an 8-K report. The filing indicates a change in its business operations and financial condition, with specific details to be provided in subsequent filings or exhibits. The company is incorporated in Delaware and its fiscal year ends on December 31st.
Why It Matters
This 8-K filing signals significant updates regarding Scorpius Holdings' financial condition and operations, which could impact investor decisions.
Risk Assessment
Risk Level: medium — 8-K filings often precede significant corporate events or financial disclosures that can introduce volatility.
Key Players & Entities
- Scorpius Holdings, Inc. (company) — Registrant
- NightHawk Biosciences, Inc. (company) — Former company name
- HEAT BIOLOGICS, INC. (company) — Former company name
- March 7, 2024 (date) — Date of report
FAQ
What specific changes in operations or financial condition are being reported by Scorpius Holdings, Inc.?
The filing indicates changes in 'Results of Operations and Financial Condition' and 'Regulation FD Disclosure', but the specific details are not provided in this initial 8-K header and are likely contained within the referenced exhibits or subsequent filings.
When did Scorpius Holdings, Inc. change its name from NightHawk Biosciences, Inc.?
The filing states the date of name change from NightHawk Biosciences, Inc. was May 2, 2022.
What is the IRS Employer Identification Number for Scorpius Holdings, Inc.?
The IRS Employer Identification Number for Scorpius Holdings, Inc. is 26-2844103.
What is the SIC code for Scorpius Holdings, Inc.?
The Standard Industrial Classification (SIC) code for Scorpius Holdings, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What is the business address of Scorpius Holdings, Inc.?
The business address for Scorpius Holdings, Inc. is 627 Davis Drive, Suite 400, Morrisville, NC 27560.
Filing Stats: 889 words · 4 min read · ~3 pages · Grade level 11.2 · Accepted 2024-03-07 08:40:10
Key Financial Figures
- $0.0002 — nge on which registered Common Stock, $0.0002 par value per share SCPX NYSE America
Filing Documents
- scpx_8k.htm (8-K) — 31KB
- ex99x1.htm (EX-99.1) — 14KB
- ex99x2.htm (EX-99.2) — 30KB
- image_002.jpg (GRAPHIC) — 30KB
- image_003.jpg (GRAPHIC) — 86KB
- image_004.jpg (GRAPHIC) — 40KB
- image_005.jpg (GRAPHIC) — 50KB
- image_006.jpg (GRAPHIC) — 38KB
- image_007.jpg (GRAPHIC) — 64KB
- image_008.jpg (GRAPHIC) — 59KB
- image_009.jpg (GRAPHIC) — 51KB
- image_010.jpg (GRAPHIC) — 51KB
- image_011.jpg (GRAPHIC) — 46KB
- image_012.jpg (GRAPHIC) — 57KB
- image_013.jpg (GRAPHIC) — 64KB
- image_014.jpg (GRAPHIC) — 47KB
- image_015.jpg (GRAPHIC) — 38KB
- image_016.jpg (GRAPHIC) — 50KB
- image_017.jpg (GRAPHIC) — 37KB
- image_018.jpg (GRAPHIC) — 63KB
- image_019.jpg (GRAPHIC) — 46KB
- image_001.jpg (GRAPHIC) — 10KB
- 0001079973-24-000328.txt ( ) — 1581KB
- nhwk-20240307.xsd (EX-101.SCH) — 3KB
- nhwk-20240307_def.xml (EX-101.DEF) — 26KB
- nhwk-20240307_lab.xml (EX-101.LAB) — 36KB
- nhwk-20240307_pre.xml (EX-101.PRE) — 25KB
- scpx_8k_htm.xml (XML) — 5KB
01. Regulation
Item 7.01. Regulation FD Disclosure. The Company will be making several presentations to investors over the next several weeks. In connection with the presentations, the Company intends to discuss the investor presentation, which is furnished as Exhibit 99.2 to this Current Report on Form 8-K. The information in this Item 7.01 and in the investor presentation furnished as Exhibit 99.2 to this Current Report on Form 8-K shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this Item 7.01 shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. The investor presentation furnished as Exhibit 99.2 to this Current Report on Form 8-K includes "safe harbor" language pursuant to the Private Securities Litigation Reform Act of 1995, as amended, indicating that certain statements contained therein are "forward-looking" rather than historical.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. The following exhibits are filed with this Current Report on Form 8-K: Exhibit Number Description 99.1 Press release dated March 7, 2024 99.2 Investor Presentation dated March 7, 2024 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: March 7, 2024 SCORPIUS HOLDINGS, INC. By: /s/ Jeffrey Wolf Name: Jeffrey Wolf Title: Chairman, President and Chief Executive Officer